Your browser doesn't support javascript.
loading
Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize Recurrence.
Alaimo, Laura; Moazzam, Zorays; Brown, Zachary J; Endo, Yutaka; Ruzzenente, Andrea; Guglielmi, Alfredo; Aldrighetti, Luca; Weiss, Matthew; Bauer, Todd W; Alexandrescu, Sorin; Poultsides, George A; Maithel, Shishir K; Marques, Hugo P; Martel, Guillaume; Pulitano, Carlo; Shen, Feng; Soubrane, Olivier; Koerkamp, Bas Groot; Endo, Itaru; Pawlik, Timothy M.
Afiliação
  • Alaimo L; Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
  • Moazzam Z; Department of Surgery, University of Verona, Verona, Italy.
  • Brown ZJ; Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
  • Endo Y; Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
  • Ruzzenente A; Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
  • Guglielmi A; Department of Surgery, University of Verona, Verona, Italy.
  • Aldrighetti L; Department of Surgery, University of Verona, Verona, Italy.
  • Weiss M; Department of Surgery, Ospedale San Raffaele, Milan, Italy.
  • Bauer TW; Department of Surgery, Johns Hopkins Hospital, Baltimore, MD, USA.
  • Alexandrescu S; Department of Surgery, University of Virginia, Charlottesville, VA, USA.
  • Poultsides GA; Department of Surgery, Fundeni Clinical Institute, Bucharest, Romania.
  • Maithel SK; Department of Surgery, Stanford University, Stanford, CA, USA.
  • Marques HP; Department of Surgery, Emory University, Atlanta, GA, USA.
  • Martel G; Department of Surgery, Curry Cabral Hospital, Lisbon, Portugal.
  • Pulitano C; Department of Surgery, University of Ottawa, Ottawa, ON, Canada.
  • Shen F; Department of Surgery, Royal Prince Alfred Hospital, University of Sydney, Sydney, NSW, Australia.
  • Soubrane O; Department of Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
  • Koerkamp BG; Department of Hepatobiliopancreatic Surgery and Liver Transplantation, AP-HP, Beaujon Hospital, Clichy, France.
  • Endo I; Department of Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Pawlik TM; Department of Gastroenterological Surgery, Yokohama City University School of Medicine, Yokohama, Japan.
Ann Surg Oncol ; 30(3): 1340-1349, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36029379
ABSTRACT

PURPOSE:

To investigate recurrence patterns after surgery for intrahepatic cholangiocarcinoma (ICC) relative to lymph node status, tumor extension, tumor burden score (TBS), and adjuvant chemotherapy.

METHODS:

Patients who underwent curative-intent resection for ICC from 1990 to 2020 were enrolled from a multi-institutional database. The hazard function was applied to plot the hazard rates over time, with further stratification by T and N AJCC 8th edition categories, TBS, and adjuvant chemotherapy.

RESULTS:

A total of 1192 patients underwent curative-intent resection for ICC and 59.9% experienced recurrence. Overall, the peak of recurrence occurred at 6.6 months. Among patients with negative lymph nodes, the T4-category had a higher peak rate of recurrence (0.1199 at 10.2 months) compared with other T-categories, while high TBS had an earlier peak of recurrence (4.2 months) compared with lower TBS. Among patients with N1 disease, T2-T4 categories had multipeak patterns of recurrence with higher hazard rates during the first 3 years after surgery in comparison with T1-category, while patients with high TBS had an earlier (4.0 months) and higher hazard peak rate compared with lower TBS groups. The administration of adjuvant chemotherapy was associated with delayed hazard rates of recurrence for N1 (4 months) and NX (6 months) categories.

DISCUSSION:

The novel application of the hazard function to assess hazard rates and timing patterns of recurrence following resection for ICC demonstrated that recurrence varied based on T- and N-categories, as well as TBS. Hazard function-based recurrence data may be helpful to tailor counseling, surveillance, and adjuvant therapy recommendations.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Ann Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Ann Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos